‘Modi govt will not tolerate this’: HRD minister to universities against CAA

News Network
December 30, 2019

Kolkata, Dec 30: As anti-citizenship law protests in various universities showed no signs of let up, Union HRD Minister Ramesh Pokhriyal on Sunday said the central government will not tolerate educational institutions turning into hubs of politicking “at any cost”.

He said that anyone is free to engage in political activities, but colleges and universities should be kept out of it, as many students come to study from far-off places.

“The Narendra Modi government is not going to tolerate this at any cost,” he asserted.

Scores of students from universities across the country, including Jawaharlal Nehru University, Jamia Millia Islamia, Delhi University, Jadavpur University and Presidency University, have been protesting against the Citizenship Amendment Act (CAA).

Pokhriyal accused the opposition parties of deliberately spreading misinformation over the CAA. “It is the Congress, which is responsible for the country’s division on religious grounds, that is spreading misinformation about CAA,” he said.

Taking a swipe at West Bengal Chief Minister Mamata Banerjee for opposing the citizenship law, the minister said the TMC supremo was the one to protest against illegal immigration in the state in 2005 when she was an MP.

 “She had vociferously demanded the Citizenship Amendment Bill back then,” he said.

On the new education policy that is under works, Pokhriyal said it would be connected with the values of the country.

 “The new education policy, which will be brought out after a gap of 33 years, will be India-centric and connected with the country’s values,” he said.

Pokhriyal said the country’s education will advance through knowledge, science and investigation.

He sought to justify the Centre’s decision to grant citizenship to religious minorities from Pakistan, Afghanistan and Bangladesh, contending that these countries are “not secular”.

The minister said that during Partition, religious minorities -- including Hindus, Buddhists, Sikhs, Jains and Christians -- accounted for “over 23 per cent” of Pakistan’s population, but the figure stands at “around 3 per cent” at present.

 “I want to ask Mamataji, where have these people gone and the Congress should also give an answer as to whether they were forced to change religion or killed or forced to flee?” he said.

Pokhriyal claimed that the Muslim population in India has grown from “9 per cent during Independence to 14 per cent at present”.

“The opposition is referring to Article 14 of the Constitution, but the Constitution is for the citizens of the country and it is not a charity house for the whole world,” he said, asserting that there is equality for every citizen irrespective of religion.

Pokhriyal said there is “no bigger” a well-wisher of Muslims of the country than Prime Minister Narendra Modi.

Asked about the protests against West Bengal Governor Jagdeep Dhankhar at universities, he said it is the failure of the state government and an indication that law and order situation is “slipping out of the hands” of the administration.

Comments

Paul
 - 
Tuesday, 31 Dec 2019

Division an all round standing ovation!!  Stoke the masses cause divide and confused beliefs-amongst the citizens - students; bring in harsh measures at ...Quote ..." at any cost" implement changes of laws etc etc. It's like reading the ABC (Alternating Beurocratic  Crap) of simpletons.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 28,2020

New Delhi, Apr 28: Nafisa Ali took to Instagram to share the inspiring story of her niece, Diya Naidu, who donated her plasma to help patients suffering from Covid-19 after recovering from the disease. The veteran actress shared a photo of her niece from the hospital bed and asked fans to read Diya's post to get a detailed account of her experience.

Nafisa wrote, "Diya Naidu my niece - a COVID19 hero - is back home after donating her plasma - looks like liquid gold - it’s value is priceless as it will save lives. So please read her COVID19 story and share the information that is first hand. It is the need of the hour. Help save lives. #diyanise. #diyanaidu #covid_19 #india (sic)."

Diya Naidu, who is a dancer and choreographer based in Bengaluru, revealed in her Instagram post that she has donated her plasma for other Covid-19 patients. She said that the method has been super effective wherever it's been tried.

Earlier, Nafisa Ali gave a shout-out to her niece on Instagram and penned a heartfelt note for her. She wrote, "I am so grateful to you brave child - a COVID19 warrior (living in Bangalore) has agreed to donate her plasma to help cure other COVID19 serious patients (sic)."

Explaining the process of plasma therapy to treat Covid-19 patients, she wrote, "The process of donating plasma to treat COVID-19 is not very complex and can be done in just two hours. One of the most discussed methods of treatment of the disease caused by the novel coronavirus is plasma therapy, which involves the transfusion of plasma from a convalescent coronavirus patient to a critical patient. The blood of a recovering patient is rich in antibodies produced by the body to fight the virus, which are expected to help the critical patient recover (sic)."

Plasma therapy has been suggested to treat people suffering from Covid-19. People, who have recovered from the disease, are donating plasma as it contains antibodies to fight the disease. Earlier, Kanika Kapoor, who was the first Bollywood celebrity to be diagnosed with the disease, also offered to donate her plasma. She has recovered from Covid-19 and is currently living with her family in Lucknow.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 19,2020

Chennai, Jan 19: Amid ongoing nationwide protests against Citizenship (Amendment) Act, 2019, finance minister Nirmala Sitharaman on Sunday said that as many as 2838 people from Pakistan were given citizenship during the last six years.

"In the last six years, as many as 2838 Pakistani refugees, 914 Afghan refugees, 172 Bangladeshi refugees including Muslims have been given Indian citizenship. From 1964 to 2008, more than 4,00,000 Tamils (from Sri Lanka) have been given Indian citizenship," Sitharaman said at 'Programme on Citizenship (Amendment) Act, 2019' event here.

She added, "Till 2014, over 566 Muslims from Pakistan, Bangladesh and Afghanistan were given Indian citizenship. During 2016-18 under Modi government, around 1595 Pakistani migrants and 391 Afghanistani Muslims were given Indian citizenship."

The minister, further, said, "It was also during the same period in 2016, that Adnan Sami was given Indian citizenship, this is an example."    

Sitharaman added that people who came from East Pakistan have been settled at various camps in the country.

"They are still there and it's been 50-60 years now. If you visit these camps, your heart will cry. The situation is the same with Sri Lankan refugees who continue to live in camps. They're barred from getting basic facilities," she said.

Asserting that the government is not snatching away anyone's citizenship, the BJP leader said: "This Citizenship (Amendment) Act is an attempt to provide people with a better life. We are not snatching away anyone's citizenship, we are only providing them that."

"The National Population Register (NPR) will be updated every 10 years and is not involved with the National Register of Citizens (NRC). Some are involved in raising false allegations and triggering people unnecessarily without any base," she added.

Comments

indian
 - 
Monday, 20 Jan 2020

Hello Madam,

What Are you ?? Are you a Finance Minister or External Affairs Minister ??

when someone asked about the economy which well related to your ministry you won't even open your mouth, 

but now you are talking about a matter which is not at all your business...

WellWisher
 - 
Sunday, 19 Jan 2020

What a pefect  figure  given by our short time  finance minister. Hope  she wil feed them from her person income wthout ONION.

Fairman
 - 
Sunday, 19 Jan 2020

Stupid, dont know even what they talk.

 

 

It is not snatching anybody's nationality. You dont have right to do it.

 

 
The subject is not snatching,    the subject is disccimination while giving nationality.

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.